Ignite Creation Date:
2025-12-25 @ 4:57 AM
Ignite Modification Date:
2026-04-09 @ 3:06 PM
Study NCT ID:
NCT01238718
Status:
COMPLETED
Last Update Posted:
2011-08-24
First Post:
2010-11-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Use of Lidocaine in Rapid Sequence Induction
Sponsor:
University of Athens
Organization:
Study Overview
Official Title:
Impact of Lidocaine on Anesthetic Depth During Rapid Sequence Induction
Status:
COMPLETED
Status Verified Date:
2010-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Lidocaine has been shown to blunt the cardiovascular response to endotracheal intubation. The incidence of hypertension, tachycardia and dysrhythmias due to laryngoscopy may be increased in patients that receive rapid sequence induction and intubation, where opioids are spared and intravenous anesthetic agents are not titrated step by step. Our hypothesis was that lidocaine when administered intravenously in patients who undergo rapid sequence induction may not only blunt the hemodynamic response to intubation, but may also increase the anesthetic depth (as assessed by BIS), thus further reducing the possibility of hypertension, arrhythmias and also awareness.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: